| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2009 | Abdominal tuberculosis in Southeastern Taiwan: 20 years of experience | Chen H.-L.; MING-SHIANG WU ; Chang W.-H.; Shih S.-C.; Chi H.; Bair M.-J. | Journal of the Formosan Medical Association | 34 | 34 | |
| 2018 | Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma | Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; MING-SHIANG WU ; TUNG-HUNG SU ; CHUN-JEN LIU ; Hu K.-C. | Helicobacter | 1 | 0 | |
| 2014 | Clinical presentations of patients from different age cohorts with biliary tract stone diseases | Hu K.-C.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Lin S.-C.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of Gastroenterology and Hepatology (Australia) | 9 | 6 | |
| 2019 | Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; TUNG-HUNG SU ; WEI-CHIH LIAO ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Clinical Infectious Diseases | 14 | 14 | |
| 2022 | Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum | Kuo Y.-C.; Yu L.-Y.; Wang H.-Y.; Chen M.-J.; MING-SHIANG WU ; Liu C.-J.; Lin Y.-C.; Shih S.-C.; Hu K.-C. | World Journal of Gastrointestinal Oncology | 2 | 0 | |
| 2009 | An ellipsometric study on the density and functionality of antibody layers immobilized by a randomly covalent method and a protein a-oriented method | Wang D.-S.; Chang C.-C.; Shih S.-C.; Lin C.-W. | Biomedical Engineering - Applications, Basis and Communications | 9 | 8 | |
| 2005 | Expression patterns of transforming growth factor-beta and its receptors in gastric mucosa of patients with refractory gastric ulcer | Shih S.-C.; Tseng K.-W.; Lin S.-C.; Kao C.-R.; Chou S.-Y.; Wang H.-Y.; Chang W.-H.; Chu C.-H.; Wang T.-E.; CHUNG-LIANG CHIEN | World Journal of Gastroenterology | 18 | 17 | |
| 2021 | Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article | Lin Y.-C.; Wang H.-Y.; Kuo Y.-C.; Chen M.-J.; MING-SHIANG WU ; CHUN-JEN LIU ; Yang H.W.; Shih S.-C.; Yu L.-Y.; Ko H.-J.; Yeh H.-I.; Hu K.-C. | Medicine | 2 | 1 | |
| 2019 | Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque | Yu L.-Y.; Hu K.-C.; CHUN-JEN LIU ; Hung C.-L.; Bair M.-J.; Chen M.-J.; Wang H.-Y.; MING-SHIANG WU ; Shih S.-C.; Liu C.-C. | Medicine | 8 | 8 | |
| 2016 | How Does Aging Affect Presentation and Management of Biliary Stones? | Hu K.-C.; Chu C.-H.; Wang H.-Y.; Chang W.-H.; Lin S.-C.; Liu C.-C.; WEI-CHIH LIAO ; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | Journal of the American Geriatrics Society | 7 | 5 | |
| 2017 | Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Oncotarget | 16 | 15 | |
| 1999 | Immunohistochemical studies of transforming growth factor-β and its receptors in the gastric mucosa of patients with refractory gastric ulcer | Shih S.-C.; CHUNG-LIANG CHIEN ; Tseng K.-W.; Lin S.-C.; Kao C.-R. | Journal of the Formosan Medical Association | 10 | 7 | |
| 2008 | Intercellular invasion of Helicobacter pylori and delayed healing of a gastric ulcer [11] | Wang S.-Y.; CHUNG-LIANG CHIEN ; Shih S.-C. | American Journal of Gastroenterology | 0 | 1 | |
| 2014 | Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease | Hu K.-C.; Wang H.-Y.; Liu S.-C.; Liu C.-C.; Hung C.-L.; Bair M.-J.; CHUN-JEN LIU ; MING-SHIANG WU ; Shih S.-C. | World Journal of Gastroenterology | 25 | 22 | |
| 2012 | Percutaneous transgastric traction-assisted esophageal endoscopic submucosal dissection: A randomized controlled trial in a porcine model | Chen P.-J.; Huang W.-C.; HSIU-PO WANG ; Chang W.-K.; Hsieh T.-Y.; Shih S.-C.; Wang H.-Y.; Liu C.-Y. | Scandinavian Journal of Gastroenterology | 6 | 3 | |
| 2016 | Pigment epithelium derived factor peptide protects murine hepatocytes from carbon tetrachloride-induced injury | Shih S.-C.; Ho T.-C.; SHOW-LI CHEN ; Tsao Y.-P. | PLoS ONE | 7 | 6 | |
| 2017 | Pigment epithelium-derived factor (PEDF) peptide promotes the expansion of hepatic stem/progenitor cells via ERK and STAT3-dependent signaling | Shih S.-C.; Ho T.-C.; SHOW-LI CHEN ; Tsao Y.-P. | American Journal of Translational Research | 11 | ||
| 2011 | Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) | Ho T.-C.; SHOW-LI CHEN ; Shih S.-C.; Chang S.-J.; Yang S.-L.; Hsieh J.-W.; Cheng H.-C.; Chen L.-J.; Tsao Y.-P. | Journal of Biological Chemistry | 32 | 31 | |
| 2014 | Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor | Tsai T.-H.; Shih S.-C.; Ho T.-C.; Ma H.-I.; Liu M.-Y.; SHOW-LI CHEN ; Tsao Y.-P. | PLoS ONE | 29 | 31 | |
| 2010 | Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells | Ho T.-C.; SHOW-LI CHEN ; Shih S.-C.; Wu J.-Y.; Han W.-H.; Cheng H.-C.; Yang S.-L.; Tsao Y.-P. | American Journal of Pathology | 41 | 38 |
